Longboard Pharmaceuticals, Inc. — Form D
Longboard Pharmaceuticals, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-11-18. The offering totals $56.0M, of which $56.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2020-11-18
- Form: D
- Accession: 0001832168-20-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $56.0M
- Amount sold: $56.0M
- Investors: 17
- Date of first sale: 2020-10-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-380882
Issuer
- Name: Longboard Pharmaceuticals, Inc.
- CIK: 0001832168
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 6154 NANCY RIDGE DRIVE, SAN DIEGO, CA, 92121
- Phone: 619-592-9775
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Vincent R Aurentz | Director | San Diego, CA |
| Chandra R Leo | Director | San Diego, CA |
| Kevin R Lind | Director | San Diego, CA |
| Laurie R Stelzer | Director | San Diego, CA |
| Kevin R Lind | Executive Officer | San Diego, CA |
More